- 专利标题: Nanoparticle-based tumor-targeted drug delivery
-
申请号: US13224399申请日: 2011-09-02
-
公开(公告)号: US09616137B2公开(公告)日: 2017-04-11
- 发明人: Ralph A. Reisfeld , Rong Xiang , Yunping Luo , Debbie Liao , Ze Liu , Tingmei Chen , Si Chen , Dan Lu
- 申请人: Ralph A. Reisfeld , Rong Xiang , Yunping Luo , Debbie Liao , Ze Liu , Tingmei Chen , Si Chen , Dan Lu
- 申请人地址: US CA La Jolla
- 专利权人: The Scripps Research Institute
- 当前专利权人: The Scripps Research Institute
- 当前专利权人地址: US CA La Jolla
- 代理机构: Olson & Cepuritis, Ltd.
- 主分类号: A61K47/48
- IPC分类号: A61K47/48 ; B82Y5/00 ; A61K9/127
摘要:
The present invention provides an aqueous tumor-targeting liposome nanoparticle composition comprising an aqueous dispersion of liposome nanoparticles. The nanoparticles preferably encapsulate an anti-cancer chemotherapeutic agent, which can be added to a pre-formed liposome composition or can be incorporated in the liposomes during the formation of the liposomes. The liposome nanoparticles comprise a legumain-targeting lipid admixed with one or more other micelle or vesicle-forming lipid materials in the form of nanoparticulate liposomes dispersed in an aqueous carrier. A preferred tumor-targeting liposome nanoparticle composition comprises (a) a legumain-targeting lipid component, (b) a zwitterionic lipid component; (c) an amino-substituted lipid component; (d) a neutral lipid component; and (e) polyethylene glycol-conjugated lipid component. The legumain-targeting lipid component comprising a hydrophobic lipid portion covalently attached to a legumain-binding moiety.
公开/授权文献
- US20120058177A1 NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY 公开/授权日:2012-03-08
信息查询